These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 428184)

  • 1. A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk.
    Tallarida RJ; Murray RB; Eiben C
    Clin Pharmacol Ther; 1979 Apr; 25(4):381-90. PubMed ID: 428184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physician attitudes toward the reporting of adverse drug reactions on the Pomeranian region].
    Schetz D; Sein Anand J
    Przegl Lek; 2015; 72(9):475-8. PubMed ID: 26827571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse drug reactions and a program of voluntary notification: an opinion survey of primary care physicians].
    Serrano Cózar G; Esteban Calvo C; Gijón Porta JA; Vaquero Turiño I; Vázquez Burgos MI; Ibáñez Ruiz C; Frías Iniesta J
    Aten Primaria; 1997 Apr; 19(6):307-12. PubMed ID: 9264670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.
    Ekman E; Bäckström M
    Eur J Clin Pharmacol; 2009 Jan; 65(1):43-6. PubMed ID: 18825377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.
    Mühlbauer V; Mühlhauser I
    BMC Health Serv Res; 2015 Nov; 15():505. PubMed ID: 26554666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' awareness of nonapproved drug indications in Slovenia.
    Kos M; Wertheimer AI; Mrhar A
    Am J Health Syst Pharm; 2006 Nov; 63(22):2184, 2186. PubMed ID: 17090735
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors Affecting Adverse Drug Reaction Reporting of Healthcare Professionals and Their Knowledge, Attitude, and Practice towards ADR Reporting in Nekemte Town, West Ethiopia.
    Gurmesa LT; Dedefo MG
    Biomed Res Int; 2016; 2016():5728462. PubMed ID: 28042569
    [No Abstract]   [Full Text] [Related]  

  • 9. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.
    Petri M; Bechtel B; Dennis G; Shah M; McLaughlin T; Kan H; Molta C
    Lupus; 2014 Sep; 23(10):1006-13. PubMed ID: 24786783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study on drug utilization in primary care depending on the professionals and family consumers].
    Sáenz MC; Mateos Campos R; Arce Arce JJ
    Aten Primaria; 1990 Mar; 7(3):206-8, 210. PubMed ID: 2129680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physicians´ insight about adverse drug reaction to frequently used medication groups in Bogotá (Colombia)].
    Buendía JA; Zuluaga AF
    Biomedica; 2014; 34(3):403-8. PubMed ID: 25504127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
    Lorimer S; Cox A; Langford NJ
    J Clin Pharm Ther; 2012 Apr; 37(2):148-52. PubMed ID: 21592157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rating the severity of the medical consequences of drug-induced liver injury.
    Slavin DE; Schlichting CL; Freston JW
    Regul Toxicol Pharmacol; 2005 Nov; 43(2):134-40. PubMed ID: 16143438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.
    Grenouillet-Delacre M; Verdoux H; Moore N; Haramburu F; Miremont-Salamé G; Etienne G; Robinson P; Gruson D; Hilbert G; Gabinski C; Bégaud B; Molimard M
    Intensive Care Med; 2007 Dec; 33(12):2150-7. PubMed ID: 17653528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing an explanatory model of nurses' intention to report adverse drug reactions in hospital settings.
    Angelis A; Pancani L; Steca P; Colaceci S; Giusti A; Tibaldi L; Alvaro R; Ausili D; Vellone E
    J Nurs Manag; 2017 May; 25(4):307-317. PubMed ID: 28127821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India.
    Panja B; Bhowmick S; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sen A; Sarkar M; Ram AK; Mukherjee PK
    Indian J Pharmacol; 2015; 47(1):126-7. PubMed ID: 25821329
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.